Timothy Quinn, MD
Family Medicine · Ridgeland, MSNPI 1447350483
Payments from drug & device makers
Across 205 payments — averaging $38,996 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$7.2M
- Merck$402K
- Pfizer$350K
- Exact Sciences$9K
- Lilly USA, LLC$4K
- Novo Nordisk$2K
- plus $3K from 21 others
Across 10 payments — averaging $12,102 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$121K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 36 | $7,224,762 |
| Merck | 7 | $402,149 |
| Pfizer | 53 | $349,625 |
| Exact Sciences | 7 | $9,019 |
| Lilly USA, LLC | 16 | $4,490 |
| Novo Nordisk | 44 | $1,558 |
| Scynexis, Inc. | 4 | $926 |
| Welch Allyn | 1 | $648 |
| Medtronic(2 entities) | 2 | $200 |
| AstraZeneca | 8 | $124 |
| Baxter Healthcare | 1 | $96 |
| Rhythm Pharmaceuticals, Inc. | 1 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Amgen(2 entities) | 3 | $45 |
| Abbott | 2 | $42 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Astellas Pharma US Inc | 2 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Gilead | 1 | $33 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Global Blood Therapeutics, Inc. | 2 | $31 |
| AbbVie | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Boston Scientific | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 2 | $6 |
How this compares
$7,994,110 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Ridgeland
- Kristi TrimmRidgeland$1.2M
- Richard PriceRidgeland$10K
- Paul MatherneGulfport$14.4M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.